Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Liver Cancer”

1,606 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,606 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableLooking for participantsNCT02864485
What this trial is testing

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 20
Large-scale testing (Phase 3)Looking for participantsNCT04868149
What this trial is testing

Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Who this might be right for
Liver Cancer
The University of Hong Kong 40
Large-scale testing (Phase 3)UnknownNCT04509635
What this trial is testing

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal CancerLiver MetastasesCetuximab
Fudan University 50
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Not applicableLooking for participantsNCT07310537
What this trial is testing

Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling

Who this might be right for
Colorectal Cancer (Diagnosis)Colorectal Liver Metastasis (CRLM)Circulating Tumor DNA (ctDNA)
Erasmus Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Early research (Phase 1)Study completedNCT00327652
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases

Who this might be right for
Neoplasm MetastasisLiver NeoplasmsCarcinoma
Anza Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00168155
What this trial is testing

Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

Who this might be right for
Colorectal AdenocarcinomaLiver Metastases
Alberta Health services 70
Testing effectiveness (Phase 2)Study completedNCT02195011
What this trial is testing

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal Neoplasms
SCRI Development Innovations, LLC 26
Early research (Phase 1)Looking for participantsNCT05791448
What this trial is testing

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Who this might be right for
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more
University of Southern California 36
Testing effectiveness (Phase 2)Study completedNCT00062933
What this trial is testing

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 40
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01456078
What this trial is testing

Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsLiver Metastases
Lund University Hospital 60
Not applicableStudy completedNCT04069468
What this trial is testing

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 1,247
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Very early researchStudy completedNCT03888859
What this trial is testing

ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more
First Affiliated Hospital Xi'an Jiaotong University 12
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT01858649
What this trial is testing

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.

Who this might be right for
Metastatic Colorectal Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60
Load More Results